Bifidobacterium bifidum Enhances the Intestinal Epithelial Tight Junction Barrier and Protects against Intestinal Inflammation by Targeting the Toll-like Receptor-2 Pathway in an NF-κB-Independent Manner

Defective intestinal tight junction (TJ) barrier is a hallmark in the pathogenesis of inflammatory bowel disease (IBD). To date, there are no effective therapies that specifically target the intestinal TJ barrier. Among the various probiotic bacteria, Bifidobacterium, is one of the most widely studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sadi, Rana, Dharmaprakash, Viszwapriya, Nighot, Prashant, Guo, Shuhong, Nighot, Meghali, Do, Toan, Ma, Thomas Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347470/
https://www.ncbi.nlm.nih.gov/pubmed/34360835
http://dx.doi.org/10.3390/ijms22158070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347470/
https://www.ncbi.nlm.nih.gov/pubmed/34360835
http://dx.doi.org/10.3390/ijms22158070

Ejemplares similares